caffeic acid phenethyl ester has been researched along with tanshinone ii a in 2 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 61 | 0 | 41 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | tanshinone ii a (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 4.82 | |
| Spike glycoprotein | Betacoronavirus England 1 | 0.8 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.8 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 11.2 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 11.2 | |
| Telomerase reverse transcriptase | Homo sapiens (human) | 2.75 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.8 | |
| Procathepsin L | Homo sapiens (human) | 0.8 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.14 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.2 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.1855 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.69 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 2.14 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.59 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 6.855 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 6.855 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for caffeic acid phenethyl ester and tanshinone ii a
| Article | Year |
|---|---|
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |